RIBICHINI, Flavio Luciano
 Distribuzione geografica
Continente #
NA - Nord America 11.285
EU - Europa 8.170
AS - Asia 7.709
SA - Sud America 1.219
AF - Africa 196
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.612
Nazione #
US - Stati Uniti d'America 11.122
SG - Singapore 3.247
CN - Cina 2.546
GB - Regno Unito 2.267
RU - Federazione Russa 1.184
BR - Brasile 1.061
HK - Hong Kong 961
DE - Germania 783
FR - Francia 782
IE - Irlanda 700
IT - Italia 674
FI - Finlandia 622
SE - Svezia 621
KR - Corea 272
UA - Ucraina 202
VN - Vietnam 178
CA - Canada 77
IN - India 71
TG - Togo 67
JP - Giappone 64
TR - Turchia 56
NL - Olanda 51
BE - Belgio 47
AR - Argentina 45
MX - Messico 45
AT - Austria 44
BD - Bangladesh 43
ID - Indonesia 39
PL - Polonia 35
IR - Iran 32
ZA - Sudafrica 31
PK - Pakistan 29
EC - Ecuador 28
EG - Egitto 24
MA - Marocco 24
ES - Italia 22
IQ - Iraq 22
AU - Australia 21
SA - Arabia Saudita 19
VE - Venezuela 19
CO - Colombia 18
CZ - Repubblica Ceca 18
RO - Romania 18
PY - Paraguay 16
PE - Perù 15
UZ - Uzbekistan 15
AZ - Azerbaigian 12
IL - Israele 12
JO - Giordania 12
LT - Lituania 12
CH - Svizzera 10
KG - Kirghizistan 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
BY - Bielorussia 8
CL - Cile 8
PT - Portogallo 8
DO - Repubblica Dominicana 7
HU - Ungheria 7
OM - Oman 7
PA - Panama 7
BG - Bulgaria 6
GR - Grecia 6
MY - Malesia 6
TH - Thailandia 6
UY - Uruguay 6
CR - Costa Rica 5
DK - Danimarca 5
KZ - Kazakistan 5
NO - Norvegia 5
NP - Nepal 5
PH - Filippine 5
AL - Albania 4
AO - Angola 4
GT - Guatemala 4
LU - Lussemburgo 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
TW - Taiwan 4
AM - Armenia 3
EE - Estonia 3
GE - Georgia 3
ME - Montenegro 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
BZ - Belize 2
CI - Costa d'Avorio 2
CM - Camerun 2
ET - Etiopia 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
Totale 28.563
Città #
Southend 2.004
Singapore 1.483
Jacksonville 1.475
Chandler 1.370
Dallas 1.258
Hong Kong 958
Woodbridge 905
Dublin 688
Ashburn 647
Ann Arbor 533
Beijing 444
Houston 405
New York 371
Princeton 277
Lawrence 276
Wilmington 253
Munich 252
Helsinki 218
Jinan 210
Los Angeles 196
Nanjing 161
Verona 160
Shenyang 154
The Dalles 153
Hebei 130
Redondo Beach 123
Buffalo 119
Columbus 100
Seattle 89
Tianjin 86
Sindelfingen 82
Moscow 78
Changsha 74
São Paulo 74
Milan 73
Nanchang 70
Lomé 66
Santa Clara 64
Zhengzhou 63
Haikou 62
Seoul 61
Washington 61
Ho Chi Minh City 56
Turku 56
Guangzhou 54
Taizhou 52
Hangzhou 51
Boardman 50
Taiyuan 49
Ningbo 48
Brussels 46
Norwalk 46
Nuremberg 44
Jiaxing 43
San Francisco 43
Fuzhou 42
Frankfurt am Main 40
Redwood City 37
Tokyo 37
Brooklyn 36
Rio de Janeiro 36
Chicago 32
Redmond 32
Fairfield 31
Falkenstein 29
Hanoi 29
Kent 29
London 28
Lanzhou 26
Falls Church 25
Warsaw 25
Belo Horizonte 24
Boston 24
Rome 24
Bologna 23
Amsterdam 22
Dong Ket 22
Jakarta 22
Toronto 22
Cedar Knolls 21
Lappeenranta 21
Montreal 21
Atlanta 20
Lancaster 20
Brasília 19
Shanghai 19
Council Bluffs 18
Curitiba 18
Porto Alegre 18
Vienna 18
Johannesburg 17
Stockholm 17
Tappahannock 17
Chennai 16
Cambridge 15
Detroit 15
Phoenix 15
Tashkent 14
Dhaka 13
Baku 12
Totale 18.025
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 512
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 169
Angiography-Derived and Sensor-Wire Methods to Assess Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction 162
First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation: the Columbus's egg? 149
[The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory]. 148
[Analysis of right electrocardiographic leads in 195 normal subjects]. 139
In-stent restenosis. 138
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 137
Accuracy of Micro-Computed Tomography in Post-mortem Evaluation of Fetal Congenital Heart Disease. Comparison Between Post-mortem Micro-CT and Conventional Autopsy 134
Drug-coated balloon: Long-term outcome from a real world three-center experience 131
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. 130
Hemodynamic predictors of long term survival in end stage cystic fibrosis 130
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 130
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 128
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 127
[Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct]. 124
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease: The EXECUTIVE Trial (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease). 124
[Elective coronary angioplasty in total absence of heart surgery]. 122
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 122
Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. 121
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 121
[Bypass surgery versus percutaneous coronary intervention: evidence, indications and patient preference according to the latest European guidelines on myocardial revascularization] 121
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 120
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. 120
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). 119
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 119
A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. 118
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 118
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 117
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 116
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 116
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 116
[Primary angioplasty in acute inferior myocardial infarct with anterior ST-segment depression: the long-term follow-up]. 115
Concomitant myocardial infarction in identical twins with similar coronary lesions. 115
Short communication: staff dose reduction during coronary angiography using low framing speed. 115
[Invasive cardiological diagnosis in an ambulatory regimen of transported inpatients]. 115
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 114
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 113
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 113
[Radiologic practice and radioprotection in Italian hemodynamic laboratories]. 113
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 113
Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension 113
On-line quantitative coronary analysis in clinical practice: one step closer to reality? 112
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 112
[Emergency angioplasty in high-risk acute infarct]. 111
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 111
Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. 110
[Heart catheterization via the femoral artery with a 4 French and mobilization at 2 hours]. 110
On the current epidemic outburst of meta-analytic rage in interventional cardiology. 109
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 109
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 109
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis 109
Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer 108
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis 108
Plasma Lipoprotein (a) is not a predictor for restenosis after elective high-pressure coronary stenting. 107
Ambulation three hours after elective cardiac catheterisation through the femoral artery. 107
[Diagnostic hemodynamics in day-hospital care]. 107
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 107
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 107
Early aggressive treatment of unstable angina without on-site cardiac surgical facilities: a prospective study of acute and long-term outcome. 106
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 106
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 106
Risk stratification in acute coronary syndromes. 106
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 105
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. 104
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 104
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 104
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 103
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 103
[Quality assurance and cost control in invasive and interventional cardiology]. 102
The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention 102
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 100
Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. 100
Acute myocardial infarction: reperfusion treatment. 100
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants 100
Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. 100
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study 100
Functional mitral regurgitation: are we treating the real target? 100
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 99
First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm 99
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial. 99
Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. 98
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. 98
Is TAVI superior to surgery in high-risk patients? Insight into the concept of individual risk assessment 98
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries 97
Bioresorbable vascular scaffolds in cardiac allograft vasculopathy: a new therapeutic option. 97
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial 97
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 97
Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques. 96
Angiographic follow-up after coronary implantation of the Multilink stent: a prospective observation. 96
Early functional and structural changes of the left atrium in a patient with trastuzumab: related cardiotoxicity 96
A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages. 95
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. 95
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease 95
Excess mortality associated with progression rate in asymptomatic aortic valve stenosis 95
Unsuspected infrahepatic interruption of inferior vena cava associated with floppy mitral valve, mitral valve prolapse, and severe mitral regurgitation. 94
Asymptomatic severe aortic coarctation at old age. 94
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 94
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 93
Plasma Activity and Insertion/Deletion Plymorphism of Angiotensin-Converting Enzyme: A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis. 93
Totale 11.556
Categoria #
all - tutte 126.458
article - articoli 126.458
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 252.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.549 0 0 0 345 300 267 28 130 127 62 245 45
2021/20221.722 171 350 15 103 80 47 25 107 67 71 185 501
2022/20234.309 319 454 450 643 351 1.040 91 284 478 22 108 69
2023/20242.862 87 197 277 305 313 595 134 214 23 170 375 172
2024/20257.228 370 414 237 1.182 378 277 353 363 1.186 573 597 1.298
2025/20264.661 1.592 996 1.464 609 0 0 0 0 0 0 0 0
Totale 28.940